Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers. The most common and easiest way to take […]

Seelos Therapeutics is preparing to conduct a global study investigating its intranasal racemic ketamine SLS-002, CEO Dr Raj Mehra told Clinical Trials Arena. The Phase III trial will enrol adult patients with acute suicidal ideation and behaviour (ASIB) in major depressive disorder (MDD). The global trial will include patients from Asian countries, Western Europe and likely […]

Nearly half of all heart attacks are “silent,” which means the person experiences no symptoms at all before the cardiac event, studies have shown. Now a medical technology company aims to catch those pre-symptomatic heart conditions using the power of artificial intelligence.